Jaws Acquisition Corp.
Status: Deal Closed
U=S+W/3
W=S@11.5
IPO Proceeds, $M | $690.00M |
---|---|
IPO Date | May 14, 2020 |
CEO | Joseph L. Dowling |
Left Lead | Credit Suisse |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
General
Growth-oriented companies |
IPO Geography | Global |
Target Company | Cano Health |
Deal Announced | Nov 12, 2020 |
Deal Size, $M | $4,400.00M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | Jun 2, 2021 |
Amendment Vote | TBD |
Closing Date | Jun 3, 2021 |
Formerly JWS
CANO
CANO/W
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Jaws Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 28 filings and events
- 3 underwriters
- 3 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Barry S. Sternlicht | 59 | Chairman |
Joseph L. Dowling | 55 | Chief Executive Officer |
Michael Racich | 48 | Chief Financial Officer |
Douglas I. Ostrover | 57 | Director |
Michael Baldock | 56 | Director |
Benjamin Weprin | 41 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Credit Suisse | Joint BR | 40,200,000 | units |
Morgan Stanley | Joint BR | 9,900,000 | |
Citigroup | Joint BR | 9,900,000 | |
60,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 28 filings.